Ledger.Open graph →
SEC Form D · filed August 13, 2010

Primrose Therapeutics, Inc

Offering
$1.5M
Sold
$753K
Exemption
—
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

People & firms on this filing (4)

Mark Kessel · South San Francisco, CAExec · DirectorZachary S. Sharon · New York, NYExec · DirectorJeffrey S. Edelman · New York, NYExec · DirectorMark Kessel · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗